A few weeks ago we heard from a constituent of mine from Barrie, Greg McGinnis. He told us that the current drug plan didn't cover his basic needs in terms of Parkinson's.
Do you have any comments, Mark? You're so involved with the pharmaceutical industry in Canada. What does your research suggest? Are there lots of people with Alzheimer's who have that same challenge, where their drug plans in Canada don't cover basic requirements?